SP1 and urinary bladder carcinoma: These results clearly demonstrate that nimbolide inhibited MMP-9 activity by suppressing the binding activity of the transcription factors NF-κB, AP-1, and Sp-1 in both bladder cancer EJ and 5637 cells.